SCHEMBL18596193

SCHEMBL18596193

CCCCC(C)(O)CCCNc1ccc(C(C)C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
HPGD P15428 2/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 4/20 0.37
ALDH1A1 P00352 3/20 0.37
ABL1 P00519 1/20 0.35
CASR P41180 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
HIF1A Q16665 1/20 0.35
MAPK1 P28482 3/20 0.35
KDM4E B2RXH2 3/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
ALOX15 P16050 2/20 0.35
ALOX12 P18054 2/20 0.35
TDP1 Q9NUW8 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854855 0.82 EPHX1 (0.51) EPHX1SMN1; SMN2L3MBTL1HPGDRAB9A
SCHEMBL25562305 0.76 EPHX1 (0.54) EPHX1SMN1; SMN2L3MBTL1HPGDRAB9A
SCHEMBL12963093 0.75 EPHX1 (0.46) EPHX1SMN1; SMN2L3MBTL1HPGDRAB9A
SCHEMBL11113503 0.74 ALDH1A1 (0.47) EPHX1SMN1; SMN2L3MBTL1HPGDRAB9A
SCHEMBL2064181 0.73 MAPT (0.54) EPHX1SMN1; SMN2L3MBTL1HPGDLMNA
SCHEMBL20643916 0.73 EPHX1 (0.43) EPHX1SMN1; SMN2L3MBTL1HPGDRAB9A
SCHEMBL11117632 0.71 STK17B (0.45) EPHX1SMN1; SMN2L3MBTL1HPGDRAB9A
SCHEMBL103979 0.71 STK17A (0.55) EPHX1LMNAALDH1A1KDM4EGAA
SCHEMBL11476807 0.70 EPHX1 (0.50) EPHX1SMN1; SMN2LMNAALDH1A1ABL1
SCHEMBL16869986 0.70 SMN1; SMN2 (0.49) EPHX1SMN1; SMN2L3MBTL1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586978-B2 Anti-viral compounds ABBVIE INC. (US) 2017-03-07 US disclosed